Revance Therapeutics, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Revance Therapeutics, Inc. opposed by its competitors

Patent:
Grant Date:
Apr 24, 2024
Title:
Methods And Systems For Purifying Non-Complexed Botulinum Neurotoxin
Oppositions:
1
Patent:
Grant Date:
Jan 26, 2022
Title:
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
Oppositions:
1
Patent:
Grant Date:
Aug 2, 2017
Title:
Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions
Oppositions:
1

Want to track Revance Therapeutics, Inc.?

Feel free to send us a message here and we will get back to you